PHARMA Stock Overview
An investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Pharmaniaga Berhad Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RM 0.45 |
| 52 Week High | RM 0.51 |
| 52 Week Low | RM 0.29 |
| Beta | 1.4 |
| 11 Month Change | 21.62% |
| 3 Month Change | 34.33% |
| 1 Year Change | 15.38% |
| 33 Year Change | -48.86% |
| 5 Year Change | -14.45% |
| Change since IPO | 288.93% |
Recent News & Updates
Pharmaniaga Berhad's (KLSE:PHARMA) Shares Bounce 25% But Its Business Still Trails The Industry
Jul 18
Why Investors Shouldn't Be Surprised By Pharmaniaga Berhad's (KLSE:PHARMA) Low P/S
May 09Recent updates
Pharmaniaga Berhad's (KLSE:PHARMA) Shares Bounce 25% But Its Business Still Trails The Industry
Jul 18Why Investors Shouldn't Be Surprised By Pharmaniaga Berhad's (KLSE:PHARMA) Low P/S
May 09Pharmaniaga Berhad (KLSE:PHARMA) Shares Could Be 49% Below Their Intrinsic Value Estimate
Apr 19Insufficient Growth At Pharmaniaga Berhad (KLSE:PHARMA) Hampers Share Price
Oct 03Is There An Opportunity With Pharmaniaga Berhad's (KLSE:PHARMA) 37% Undervaluation?
Jul 19Is It Too Late To Consider Buying Pharmaniaga Berhad (KLSE:PHARMA)?
Feb 18Many Would Be Envious Of Pharmaniaga Berhad's (KLSE:PHARMA) Excellent Returns On Capital
Dec 10Bullish: Analysts Just Made A Massive Upgrade To Their Pharmaniaga Berhad (KLSE:PHARMA) Forecasts
Nov 24We Think That There Are Issues Underlying Pharmaniaga Berhad's (KLSE:PHARMA) Earnings
Aug 27Pharmaniaga Berhad (KLSE:PHARMA) Has A Somewhat Strained Balance Sheet
May 28Shareholder Returns
| PHARMA | MY Healthcare | MY Market | |
|---|---|---|---|
| 7D | 2.3% | -0.5% | 0.6% |
| 1Y | 15.4% | 11.1% | 19.9% |
Return vs Industry: PHARMA exceeded the MY Healthcare industry which returned 11.1% over the past year.
Return vs Market: PHARMA underperformed the MY Market which returned 19.9% over the past year.
Price Volatility
| PHARMA volatility | |
|---|---|
| PHARMA Average Weekly Movement | 7.6% |
| Healthcare Industry Average Movement | 3.7% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in MY Market | 11.4% |
| 10% least volatile stocks in MY Market | 2.4% |
Stable Share Price: PHARMA's share price has been volatile over the past 3 months.
Volatility Over Time: PHARMA's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 3,476 | n/a | www.pharmaniaga.com |
Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through three segments: Logistics and Distribution, Manufacturing, and Indonesia. It is involved in manufacturing, distribution, trading, wholesaling, and marketing pharmaceutical and medical products; supply, trading, and installation of medical and hospital equipment; and trading and wholesaling of consumer products.
Pharmaniaga Berhad Fundamentals Summary
| PHARMA fundamental statistics | |
|---|---|
| Market cap | RM 648.55m |
| Earnings (TTM) | -RM 57.16m |
| Revenue (TTM) | RM 3.49b |
0.2x
P/S Ratio-11.3x
P/E RatioIs PHARMA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHARMA income statement (TTM) | |
|---|---|
| Revenue | RM 3.49b |
| Cost of Revenue | RM 3.15b |
| Gross Profit | RM 336.96m |
| Other Expenses | RM 394.13m |
| Earnings | -RM 57.16m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.04 |
| Gross Margin | 9.66% |
| Net Profit Margin | -1.64% |
| Debt/Equity Ratio | -491.7% |
How did PHARMA perform over the long term?
See historical performance and comparison